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Alterations in Mitochondrial State 4/3 Transition Underlie Stress-
Induced Energetic-Redox Imbalance and Myocyte Dysfunction in Diabetic
Mice
Carlo G. Tocchetti, Brian A. Stanley, Sa Shi, Walter H. Watson,
Sonia Cortassa, Fadi G. Akar, Nazareno Paolocci, Miguel A. Aon.
Diabetes is a syndrome in which mitochondrial alterations may participate in the
dysfunction, and ultimately failure of several organs. The diabetic heart in
particular can be subjected to both glycemic level oscillations and increased
workload (via b-stimulation), events that may further deteriorate its mechanical
properties. Here we show that when diabetic heart (db/db) cells are challenged
with high levels of extracellular glucose (30 mM) and concomitant
b-adrenergic stimulation via isoproterenol (ISO), intracellular GSH is greatly
diminished while superoxide and H2O2 generation substantially increased. The
typical enhancement in sarcomere shortening and whole Ca2þ transient driven
by b-adrenergic stimulation is blunted in db/db cells, along with hampered relax-
ation and Ca2 reuptake. Mitochondria isolated from db/db hearts subjected to
high-glucose/ISO regimenexhibitmarkedly decreased coupling ratios from respi-
ratory complexes I, II, and IVwhileROSemission is greatly increased, under both
forwardand reverse electron transport. These changes reflect a profoundalteration
in the crucial (energy supplying) state 4/3 transition that ultimately results in
loweredATP synthesis and in a ‘‘non-stop’’ reactive oxygen species (ROS) emis-
sion in the presence ofADP. Incubating high-glucose/ISO treateddb/dbmyocytes
with cell-permeable GSH restores intracellular GSH, blunts ROS production and
fully rescues contractility/relaxation in thesemyocytes. These results show the di-
rect role played by an oxidized redox environment in triggering the negative syn-
ergy among mitochondrial ROS and energetics leading to the E-C coupling
impairment. Our study maps mitochondrial sites, i.e. state 4/3 transition, that
in diabetic heart cells account, at least in part, for excess ROS emission and
loss in energy supply when metabolically and energetically challenged.
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The Role of Reactive Oxygen Species in Contractile Dysfunction Following
Ischemia/Reperfusion
Laura D. Gauthier, Joseph L. Greenstein, Raimond L. Winslow.
Myocardial stunning occurs following ischemia-reperfusion, and is characterized
bydepressedcontractility and elevated resting tension that is distinct fromdysfunc-
tion associated with tissue damage or death. A wide variety of factors have been
shown to contribute to post-ischemic myocardial dysfunction including cytosolic
Ca2þ overload, acidosis, and the damaging effects of degradative enzymes and free
radicals such as reactive oxygen species (ROS). Thesemechanisms act over awide
range of timescales. Intracellular Ca2þ, Naþ, and pH return to near pre-ischemic
levels within a matter of minutes, while ROS production persists for up to three
hours. The symptoms of myocardial stunning can persist even longer, indicative
of a modified redox environment in the myocyte. Studies have revealed a number
of sources of ROS production during reperfusion, but the mitochondria’s role in
regulating the balance of electron-carrying redox couples implicates cellular respi-
ration as a critical source of ROS. In the modeling work presented here, we link
a mathematical model of mitochondrial respiration and ROS production with
amodel of excitation-contraction coupling in the guinea pigmyocyte. Experimen-
tally determinedROS-dependentmodulation of ryanodine receptors, sarcoplasmic
reticulum (SR) Ca2þATPase, Naþ-KþATPase and myofilaments is incorporated
into our model. Using this integrated model, we show that contractile
dysfunction associated with myocardial stunning persists after ROS-mediated
alterations in protein function. ROS-related changes in Naþ-Kþ ATPase flux
lead to altered intracellular Naþ, which modulates diastolic intracellular Caþ via
theNaþ-Ca2þ exchanger. Reduced SRCa2þATPase activity and increased ryano-
dine receptor leak cause decreased SR Ca2þ load. Finally, ROS-related alteration
of myofilament proteins reduces their Ca2þ sensitivity, which also contributes to
decreased contractile force. Taken together, all of these mechanisms lead to con-
tractile dysfunction caused by mitochondria-derived ROS.
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Ec Coupling is Preserved in Ncx Knockout Mice Exposed to Metabolic
Inhibitors
Kim Henderson, Rui Zhang, Ken Philipson, Bridge H.B. John,
Josh Goldhaber.
To determine whether ablating the cardiac sodium-calcium exchanger (NCX)
prevents couplon loss during metabolic inhibition (MI), we recorded Ca tran-
sients or resting Ca spark frequency (CaSpF) in ventricular myocytes isolated
fromWT and ventricular-specific NCX knockout (KO)mice. In field stimulated
myocytes loaded with 10 mM Fluo-3 AM, application of the mitochondrial and
glycolytic inhibitors FCCP (50 nM) and 2-DG (10mM) reducedCa transients by
54.25 3.3% in WT but only by 19.05 6.0% in KO (p <0.05). Similarly, MI
suppressed action potential evoked Ca sparks in patch clamped WT myocytes
loaded with 1 mM fluo-3 salt by 60.0 5 8.2% (p <0.05), but in KO by only33.0 5 3.4%. The reduction in ICa during MI was similar for both WT and
KO and SR Ca stores remained at control levels in both cell types during MI.
In patch clamped myocytes loaded with 1 mM K5Fluo-3 and held at 75 mV,
MI reduced resting CaSpF in WT by 92.45 6.7%, (p=0.008) but had no effect
on CaSpF in KO Abolishing Na and Ca gradients by using the same ‘‘internal’’
solution for both the bath and pipette (current clampmode, VRest = 0mV), elim-
inated the KO’s resistance toMI, causing CaSpF to decline to a similar extent in
both WT and KO (59.05 6.2% and 60.75 10.9%, respectively). This finding
suggests that elevated diadic cleft Ca, a major characteristic of KO myocytes
(Pott et al, Biophys J, 92: 1431, 2007; Neco et al. Biophys J, 99: 755, 2010),
maintains effective triggering of SR Ca release during MI despite reduced ICa.
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Mechanisms Regulating the Organellar Ca2þ Dynamics in Intact Hearts
During Ischemia-Reperfusion
Dmytro Kornyeyev, Azade D. Petrosky, Ariel L. Escobar.
The accumulation of Ca2þ during ischemia, in both cytosol and sarcoplasmic
reticulum(SR) of ventricular cardiomyocytes, contributes to the condition known
as myocardial stunning. This not only disrupts normal Ca2þ dynamics in the
contractile cells but also makes them more prone to apoptosis and/or
necrosis. Therefore, the identification of the mechanisms underlying this phe-
nomenon is important for understanding functional changes that occur during
cardiac infarction. We examined the role of acidosis, inhibition of Naþ/Ca2þ
exchanger (NCX) and altered restitution of Ca2þ release as factors that can
potentially be involved in the intracellularCa2þ accumulation. PulsedLocal Field
Fluorescenceexperiments onLangendorff-perfusedmousehearts reveal that ade-
crease in Tyrode solution’s pH of from 7.4 to 6.2 diminished the amplitude of
Ca2þ transients (5253% of control) without elevation of diastolic Ca2þ level
(measured with rhod-2 for cytosol and mag-fluo-4 for intra-SR). This suggests
that acidosis alone cannot be responsible for accumulation of Ca2þ in myocytes.
The combination of low pH (6.2) and partial (25%) replacement of Naþwith Liþ
(to inhibit NCX) resulted in 1.4-fold increase in resting diastolic [Ca2þ] in cytosol
suggesting that the NCX activity might contribute to ischemia-induced changes
in intracellular Ca2þ content. The restitution of Ca2þ release, measured with
double-pulse protocols, slowed down during the ischemic period. Under these
conditions, the decrease ofCa2þ release fromSRmight promote an accumulation
of Ca2þ in this cellular compartment. Simultaneous measurements of intracellu-
lar action potentials (AP) andCa2þ transients revealed that the restitution ofAP is
not the limiting step for Ca2þ release restitution during ischemia. Interestingly,
the slow restitution persisted during reperfusion leading to an amplification of
Ca2þ alternans. The study was supported by NIH R01-HL-084487 grant.
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Optical Measurement of Action Potential in Adult Ventricular Myocytes
Qinghai Tian, Martin Oberhofer, Sandra Ruppenthal, Anke Scholz,
Volker Buschmann, Andre´ Zeug, Peter Lipp, Lars Kaestner.
Due to their shape and fragility primary cells such as neurons or cardio-
myocytes cannot enter automated membrane potential measurements on
patch-clamp robots. Instead contact-free optical approaches would be ad-
vantageous. So far procedures based on potentiometric dyes are lacking
one or several of the following properties: (i) ability for quantification,
(ii) sufficiently fast response time to follow action potentials (APs), (iii)
sufficiently high signal-to-noise ratio to avoid signal averaging, (iv)
sensor-induced alterations of AP properties. We show that the small mole-
cule dye di-8-ANEPPS and the novel genetically encoded sensor ‘‘Mer-
maid’’ provide quantitative potential information. Based on an improved
optical design, individual AP could be recorded with an exceptional
signal-to-noise-ratio. The sensors were validated using the patch-clamp
technique, confocal microscopy and fluorescence lifetime imaging in com-
bination with global unmixing procedures. When applying such approaches
we identified distinctly different pharmacological profiles of APs between
adult and neonatal cardiomyocytes. We concluded that optical recordings
of individual APs can be performed using small molecule dyes and novel
genetically encoded biosensors without disturbing the properties of APs.
Additionally we have demonstrated the superiority of adult over neonatal
cardiomyocytes for pharmacological investigations such as QT-screens.
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The Differential Action of Cytocalasin D in T-tubular Remodelling of
Ventricular Myocytes
Lars Kaestner, Qinghai Tian, Sara Pahlavan, Katharina Oleinikow,
Sandra Ruppenthal, Anke Scholz, Martin Oberhofer, Christian Schumann,
Annette Kraegeloh, Peter Lipp.
Cytocalasin D (cytoD) is a fungal metabolite that inhibits cytokinesis by block-
ing formation of contractile microfilament structures resulting in multi-
nucleated cells, reversible inhibition of cell movement, and the induction of
